reference/24405687

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24405687

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1098-5514 0022-538X
issueIdentifier	3
publicationName	Journal of Virology
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6f5fe6a992fc844d7884d79b5399c5f1
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0daf5ebc9857aed0fee9d4c01e2b476b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9e6fc514249e4603f1f223473cda62f2
bibliographicCitation	Uche IK, Fowlkes N, Vu L, Watanabe T, Carossino M, Nabi R, Del Piero F, Rudd JS, Kousoulas KG, Rider PJF. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model. J Virol. 2021 Jan 13;95(3). PMID: 33177208; PMCID: PMC7925097.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07304265df8f1fedcf753b6ac43f334c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_856c8e64233e42060becf7afa4fd2661 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10b0b7a9e7dbacbbc4d7c50ae4c2a6cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d5e24ad0cd3114028bb3492da082464 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51f6d878b1f1da589c5419d4b5c20220 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e46ba8f2e7a0c2fb6ca2afa3fb124e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5702-0809 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_571e4dbd0316465fced6d4554e57a42c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f06b27df98de750d60ba46fb96bc71df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1990980fdda2e57d9e2e90e85345b4dd
date	2021-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7925097 https://doi.org/10.1128/jvi.01359-20 https://pubmed.ncbi.nlm.nih.gov/33177208
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5334 https://portal.issn.org/resource/ISSN/1098-5514 https://portal.issn.org/resource/ISSN/0022-538X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D050378Q000276 http://id.nlm.nih.gov/mesh/D018259Q000235 http://id.nlm.nih.gov/mesh/D008175Q000517 http://id.nlm.nih.gov/mesh/D008546Q000517 http://id.nlm.nih.gov/mesh/D050130Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000276 http://id.nlm.nih.gov/mesh/D008175Q000556 http://id.nlm.nih.gov/mesh/D008546Q000473 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D008546Q000276 http://id.nlm.nih.gov/mesh/D008546Q000235 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8015 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d0f9cac1efbeec6502f1d2db8ff6855 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9601 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6759 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_835377353fb5d9a3ece277c472079a19

Total number of triples: 57.